Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP265942.RA3xFoEfv54sKIswCFBx2p2lRILG3yk3QZQ45ihokhzus130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP265942.RA3xFoEfv54sKIswCFBx2p2lRILG3yk3QZQ45ihokhzus130_assertion type Assertion NP265942.RA3xFoEfv54sKIswCFBx2p2lRILG3yk3QZQ45ihokhzus130_head.
- NP265942.RA3xFoEfv54sKIswCFBx2p2lRILG3yk3QZQ45ihokhzus130_assertion description "[The CXCR4 promoter is shown to have a 'tumor-on' and 'liver-off' status in vitro and in vivo, and CXCR4 may prove to be a good candidate TSP for cancer gene therapy approaches for melanoma and breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265942.RA3xFoEfv54sKIswCFBx2p2lRILG3yk3QZQ45ihokhzus130_provenance.
- NP265942.RA3xFoEfv54sKIswCFBx2p2lRILG3yk3QZQ45ihokhzus130_assertion evidence source_evidence_literature NP265942.RA3xFoEfv54sKIswCFBx2p2lRILG3yk3QZQ45ihokhzus130_provenance.
- NP265942.RA3xFoEfv54sKIswCFBx2p2lRILG3yk3QZQ45ihokhzus130_assertion SIO_000772 15029227 NP265942.RA3xFoEfv54sKIswCFBx2p2lRILG3yk3QZQ45ihokhzus130_provenance.
- NP265942.RA3xFoEfv54sKIswCFBx2p2lRILG3yk3QZQ45ihokhzus130_assertion wasDerivedFrom befree-20140225 NP265942.RA3xFoEfv54sKIswCFBx2p2lRILG3yk3QZQ45ihokhzus130_provenance.
- NP265942.RA3xFoEfv54sKIswCFBx2p2lRILG3yk3QZQ45ihokhzus130_assertion wasGeneratedBy ECO_0000203 NP265942.RA3xFoEfv54sKIswCFBx2p2lRILG3yk3QZQ45ihokhzus130_provenance.